Nuvo Research offers commercial healthcare products that target several therapeutic areas, including pain, allergy, neurology, and dermatology. Their products include prescription products, ethical products, natural health care products, and medical devices.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Nuvo Pharmaceuticals Inc market cap is $11.17M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nuvo Pharmaceuticals Inc 52 week high is $1.25 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nuvo Pharmaceuticals Inc 52 week low is $0.4174 as of November 18, 2026.
Nuvo Pharmaceuticals Inc stock price today is $0.5559.
Nuvo Pharmaceuticals Inc stock price yesterday was $0.475.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Nuvo Pharmaceuticals Inc's P/E ratio is 0.94.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Nuvo Pharmaceuticals Inc P/B ratio is 1.8064.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Nuvo Pharmaceuticals Inc 50-day moving average is $0.9753.